Correlation Between Astellas Pharma and Johnson Johnson

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Johnson Johnson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Johnson Johnson into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and Johnson Johnson, you can compare the effects of market volatilities on Astellas Pharma and Johnson Johnson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Johnson Johnson. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Johnson Johnson.

Diversification Opportunities for Astellas Pharma and Johnson Johnson

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Astellas and Johnson is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Johnson Johnson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Johnson and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Johnson Johnson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Johnson has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Johnson Johnson go up and down completely randomly.

Pair Corralation between Astellas Pharma and Johnson Johnson

Assuming the 90 days horizon Astellas Pharma is expected to under-perform the Johnson Johnson. In addition to that, Astellas Pharma is 1.94 times more volatile than Johnson Johnson. It trades about -0.02 of its total potential returns per unit of risk. Johnson Johnson is currently generating about 0.04 per unit of volatility. If you would invest  13,454  in Johnson Johnson on August 25, 2024 and sell it today you would earn a total of  1,416  from holding Johnson Johnson or generate 10.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Astellas Pharma  vs.  Johnson Johnson

 Performance 
       Timeline  
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Johnson Johnson 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Johnson Johnson is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Astellas Pharma and Johnson Johnson Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astellas Pharma and Johnson Johnson

The main advantage of trading using opposite Astellas Pharma and Johnson Johnson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Johnson Johnson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Johnson will offset losses from the drop in Johnson Johnson's long position.
The idea behind Astellas Pharma and Johnson Johnson pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges